Ergoteles LLC Viracta Therapeutics, Inc. Transaction History

Ergoteles LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.26 - $4.38 $142,145 - $494,125	-112,814 Reduced 85.06%	19,822 $28,000
Q3 2022 Nov 14, 2022	SELL	$3.32 - $5.69 $76,114 - $130,448	-22,926 Reduced 14.74%	132,636 $566,000
Q2 2022 Aug 12, 2022	BUY	$1.87 - $5.0 $290,900 - $777,810	155,562 New	155,562 $604,000

3.66M

1.8K

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $1.13M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.